PGR and breast carcinoma: The determination of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor (HER2), and Ki-67 were useful for defining subtypes of breast cancer which provided prognostic information and generally sufficient to guide adjuvant systemic treatment for patients (Curigliano et al., 2017).